Eintrag weiter verarbeiten
A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the pre...
Gespeichert in:
Veröffentlicht in: | Blood 124(2014,21) Artikel-Nr. 5946, 1 S. |
---|---|
Personen und Körperschaften: | , |
Titel: | A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial)/ Oliver Cornely, Thibaut Leguay, Johan Maertens, Carlo Castagnola, Achilles Anagnostopoulos, Bernadino Allione, Claus Peter Heussel, J. Peter Donnelly, Samir G. Agrawal, Will Garner, Catherine Simcock, Michael J. Hawkins, Nicola Goekbuget |
Format: | E-Book-Kapitel |
Sprache: | Englisch |
veröffentlicht: |
2014
|
Gesamtaufnahme: |
: Blood, 124(2014,21) Artikel-Nr. 5946, 1 S.
, volume:124 |
Quelle: | Verbunddaten SWB Lizenzfreie Online-Ressourcen |
LEADER | 02409caa a2200517 4500 | ||
---|---|---|---|
001 | 0-1504683013 | ||
003 | DE-627 | ||
005 | 20220812011750.0 | ||
007 | cr uuu---uuuuu | ||
008 | 150630s2014 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)1504683013 | ||
035 | |a (DE-576)434683019 | ||
035 | |a (DE-599)BSZ434683019 | ||
035 | |a (OCoLC)1340697011 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
245 | 1 | 2 | |a A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial) |c Oliver Cornely, Thibaut Leguay, Johan Maertens, Carlo Castagnola, Achilles Anagnostopoulos, Bernadino Allione, Claus Peter Heussel, J. Peter Donnelly, Samir G. Agrawal, Will Garner, Catherine Simcock, Michael J. Hawkins, Nicola Goekbuget |
264 | 1 | |c 2014 | |
300 | |a 1 | ||
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Gesehen am 30.06.2015 | ||
700 | 1 | |a Cornely, Oliver Andreas |d 1967- |0 (DE-588)121712915 |0 (DE-627)081485123 |0 (DE-576)292844425 |4 oth | |
700 | 1 | |a Heußel, Claus Peter |0 (DE-588)1048631389 |0 (DE-627)780769422 |0 (DE-576)40288146X |4 oth | |
773 | 0 | 8 | |i In |t Blood |d Washington, DC : American Society of Hematology, 1946 |g 124(2014,21) Artikel-Nr. 5946, 1 S. |h Online-Ressource |w (DE-627)266886647 |w (DE-600)1468538-3 |w (DE-576)075961938 |x 1528-0020 |7 nnns |
773 | 1 | 8 | |g volume:124 |g year:2014 |g number:21 |g extent:1 |
856 | 4 | 0 | |u https://ash.confex.com/ash/2014/webprogram/Session5946.html/ |x Verlag |z kostenfrei |3 Volltext |
936 | u | w | |d 124 |j 2014 |e 21 |g 1 |y 124(2014,21) Artikel-Nr. 5946, 1 S. |
951 | |a AR | ||
856 | 4 | 0 | |u https://ash.confex.com/ash/2014/webprogram/Session5946.html/ |9 LFER |
852 | |a LFER |z 2017-09-14T00:00:00Z | ||
970 | |c OD | ||
971 | |c EBOOK | ||
972 | |c EBOOK | ||
973 | |c Aufsatz | ||
935 | |a lfer | ||
900 | |a Heußel, Claus P. | ||
900 | |a Heußel, C. P. | ||
900 | |a Heussel, Claus Peter | ||
900 | |a Heussel, Claus-Peter | ||
900 | |a Heussel, Claus P. | ||
900 | |a Cornely, Oliver A. | ||
900 | |a Cornely, Oliver | ||
900 | |a Cornely, O. A. | ||
980 | |a 1504683013 |b 0 |k 1504683013 |o 434683019 |c lfer |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=A+double-blind%2Cmulticentre%2C+randomised%2C+placebo-controlled+study+to+assess+the+efficacy%2C+safety+and+tolerability+of+prophylactic+liposomal+Amphotericin+B+%28AmBisome+%28R%29%29+for+the+prevention+of+invasive+fungal+infections+in+subjects+receiving+remission-induction+chemotherapy+for+acute+lymphoblastic+leukaemia+%28AmBiGuard+trial%29&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Adc&rft.creator=&rft.pub=&rft.format=Journal&rft.language=English&rft.issn=1528-0020 |
---|
_version_ | 1757940088777474048 |
---|---|
access_facet | Electronic Resources |
author2 | Cornely, Oliver Andreas, Heußel, Claus Peter |
author2_role | oth, oth |
author2_variant | o a c oa oac, c p h cp cph |
author_facet | Cornely, Oliver Andreas, Heußel, Claus Peter |
callnumber-sort | |
collection | lfer |
container_reference | 124(2014,21) Artikel-Nr. 5946, 1 S. |
container_title | Blood |
ctrlnum | (DE-627)1504683013, (DE-576)434683019, (DE-599)BSZ434683019, (OCoLC)1340697011 |
facet_avail | Online, Free |
finc_class_facet | not assigned |
finc_id_str | 0019909968 |
footnote | Gesehen am 30.06.2015 |
format | ElectronicBookComponentPart |
format_access_txtF_mv | Article, E-Article |
format_de105 | Ebook |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_del152 | Buch |
format_detail_txtF_mv | text-online-monograph-child |
format_dezi4 | e-Book |
format_finc | Article, E-Article |
format_legacy | ElectronicBookPart |
format_strict_txtF_mv | E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
hierarchy_parent_id | 0-266886647 |
hierarchy_parent_title | Blood |
hierarchy_sequence | 124(2014,21) Artikel-Nr. 5946, 1 S. |
hierarchy_top_id | 0-266886647 |
hierarchy_top_title | Blood |
id | 0-1504683013 |
illustrated | Not Illustrated |
imprint | 2014 |
imprint_str_mv | 2014 |
institution | DE-D117, DE-105, LFER, DE-Ch1, DE-15, DE-14, DE-Zwi2 |
is_hierarchy_id | 0-1504683013 |
is_hierarchy_title | A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial) |
isil_str_mv | LFER |
issn | 1528-0020 |
kxp_id_str | 1504683013 |
language | English |
last_indexed | 2023-02-15T23:05:11.823Z |
match_str | cornely2014adoubleblindmulticentrerandomisedplacebocontrolledstudytoassesstheefficacysafetyandtolerabilityofprophylacticliposomalamphotericinbambisomerforthepreventionofinvasivefungalinfectionsinsubjectsreceivingremissioninductionchemotherapyforacutelymphoblasticleukaemiaambiguardtrial |
mega_collection | Verbunddaten SWB, Lizenzfreie Online-Ressourcen |
misc_de105 | EBOOK |
multipart_link | 075961938 |
multipart_part | (075961938)124(2014,21) Artikel-Nr. 5946, 1 S. |
names_id_str_mv | (DE-588)121712915, (DE-627)081485123, (DE-576)292844425, (DE-588)1048631389, (DE-627)780769422, (DE-576)40288146X |
oclc_num | 1340697011 |
physical | 1 |
publishDate | 2014 |
publishDateSort | 2014 |
publishPlace | |
publisher | |
record_format | marcfinc |
record_id | 434683019 |
recordtype | marcfinc |
rvk_facet | No subject assigned |
source_id | 0 |
spelling | A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial) Oliver Cornely, Thibaut Leguay, Johan Maertens, Carlo Castagnola, Achilles Anagnostopoulos, Bernadino Allione, Claus Peter Heussel, J. Peter Donnelly, Samir G. Agrawal, Will Garner, Catherine Simcock, Michael J. Hawkins, Nicola Goekbuget, 2014, 1, Text txt rdacontent, Computermedien c rdamedia, Online-Ressource cr rdacarrier, Gesehen am 30.06.2015, Cornely, Oliver Andreas 1967- (DE-588)121712915 (DE-627)081485123 (DE-576)292844425 oth, Heußel, Claus Peter (DE-588)1048631389 (DE-627)780769422 (DE-576)40288146X oth, In Blood Washington, DC : American Society of Hematology, 1946 124(2014,21) Artikel-Nr. 5946, 1 S. Online-Ressource (DE-627)266886647 (DE-600)1468538-3 (DE-576)075961938 1528-0020 nnns, volume:124 year:2014 number:21 extent:1, https://ash.confex.com/ash/2014/webprogram/Session5946.html/ Verlag kostenfrei Volltext, https://ash.confex.com/ash/2014/webprogram/Session5946.html/ LFER, LFER 2017-09-14T00:00:00Z |
spellingShingle | A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial) |
swb_id_str | 434683019 |
title | A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial) |
title_auth | A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial) |
title_full | A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial) Oliver Cornely, Thibaut Leguay, Johan Maertens, Carlo Castagnola, Achilles Anagnostopoulos, Bernadino Allione, Claus Peter Heussel, J. Peter Donnelly, Samir G. Agrawal, Will Garner, Catherine Simcock, Michael J. Hawkins, Nicola Goekbuget |
title_fullStr | A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial) Oliver Cornely, Thibaut Leguay, Johan Maertens, Carlo Castagnola, Achilles Anagnostopoulos, Bernadino Allione, Claus Peter Heussel, J. Peter Donnelly, Samir G. Agrawal, Will Garner, Catherine Simcock, Michael J. Hawkins, Nicola Goekbuget |
title_full_unstemmed | A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial) Oliver Cornely, Thibaut Leguay, Johan Maertens, Carlo Castagnola, Achilles Anagnostopoulos, Bernadino Allione, Claus Peter Heussel, J. Peter Donnelly, Samir G. Agrawal, Will Garner, Catherine Simcock, Michael J. Hawkins, Nicola Goekbuget |
title_in_hierarchy | A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial) / Oliver Cornely, Thibaut Leguay, Johan Maertens, Carlo Castagnola, Achilles Anagnostopoulos, Bernadino Allione, Claus Peter Heussel, J. Peter Donnelly, Samir G. Agrawal, Will Garner, Catherine Simcock, Michael J. Hawkins, Nicola Goekbuget, |
title_short | A double-blind,multicentre, randomised, placebo-controlled study to assess the efficacy, safety and tolerability of prophylactic liposomal Amphotericin B (AmBisome (R)) for the prevention of invasive fungal infections in subjects receiving remission-induction chemotherapy for acute lymphoblastic leukaemia (AmBiGuard trial) |
title_sort | double blind multicentre randomised placebo controlled study to assess the efficacy safety and tolerability of prophylactic liposomal amphotericin b ambisome r for the prevention of invasive fungal infections in subjects receiving remission induction chemotherapy for acute lymphoblastic leukaemia ambiguard trial |
url | https://ash.confex.com/ash/2014/webprogram/Session5946.html/ |